Neurologia Geral Consenso da AAN sobre uso de toxina bolulínica em Neurologia 20/04/2016 by Maramelia Miranda 0 Comments Apresentado e publicado há 3 dias, no congresso da American Academy of Neurology – AAN, em Vancouver. LINK Simpson et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016. Post navigation ← A Casa Grande surta quando a Senzala aprende a lerEscore ICH no Hematoma Intraparenquimatoso → Author Maramelia Miranda